AnaptysBio Financial Overview
AnaptysBio's market cap is currently $1.36B. The company's EPS TTM is $0.52; its P/E ratio is -17.41; AnaptysBio is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.88. See an overview of income statement, balance sheet, and cash flow financials.
